PPARG and fatty liver disease: Notably, PPARγ overactivation is also associated with insulin resistance, establishing a vicious cycle of “lipotoxicity-metabolic dysregulation.”56 Intervention studies indicate that PPARγ inhibition significantly alleviates cadmium-induced hepatic steatosis.